Stockscreener 앱 받기
180.29
0.32%
0.58
시장 영업 전:
181.33
1.04
+0.58%
전일 마감가:
$179.71
열려 있는:
$180.13
하루 거래량:
7.53M
Relative Volume:
1.31
시가총액:
$286.54B
수익:
$113.10B
순이익/손실:
$16.33B
주가수익비율:
18.51
EPS:
9.7425
순현금흐름:
$10.35B
1주 성능:
+3.09%
1개월 성능:
+8.28%
6개월 성능:
+36.78%
1년 성능:
+41.30%
1일 변동 폭
$179.50
$181.98
1주일 범위
$174.30
$181.98
52주 변동 폭
$94.33
$181.98
모건 스탠리 Stock (MS) Company Profile
명칭
Morgan Stanley
전화
212-761-4000
주소
1585 BROADWAY, NEW YORK, NY
MS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MS
Morgan Stanley
|
180.29 | 285.61B | 113.10B | 16.33B | 10.35B | 9.7425 |
|
GS
Goldman Sachs Group Inc
|
911.03 | 266.71B | 126.58B | 16.67B | 57.26B | 49.23 |
|
SCHW
Charles Schwab Corp
|
97.05 | 170.25B | 27.16B | 8.23B | 20.55B | 4.2633 |
|
HOOD
Robinhood Markets Inc
|
123.38 | 121.98B | 4.23B | 2.19B | -4.36B | 2.4089 |
|
LPLA
Lpl Financial Holdings Inc
|
387.45 | 30.97B | 14.13B | 1.12B | 45.45M | 14.62 |
모건 스탠리 Stock (MS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-24 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-10-03 | 개시 | BMO Capital Markets | Outperform |
| 2025-07-09 | 업그레이드 | Keefe Bruyette | Mkt Perform → Outperform |
| 2024-11-26 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-11-15 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-10-04 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-09-11 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-08-02 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2024-07-17 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-01-17 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-01-17 | 다운그레이드 | Keefe Bruyette | Outperform → Mkt Perform |
| 2024-01-09 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2023-11-28 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2023-11-20 | 다운그레이드 | Exane BNP Paribas | Outperform → Neutral |
| 2023-10-23 | 다운그레이드 | Odeon | Buy → Hold |
| 2023-10-20 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2023-10-11 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-09-07 | 개시 | HSBC Securities | Buy |
| 2023-07-12 | 업그레이드 | Odeon | Hold → Buy |
| 2023-01-18 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-01-10 | 업그레이드 | Odeon | Sell → Hold |
| 2023-01-04 | 다운그레이드 | Wolfe Research | Outperform → Underperform |
| 2022-10-05 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-09-06 | 다운그레이드 | Odeon | Hold → Sell |
| 2022-05-03 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2022-01-28 | 다운그레이드 | Odeon | Buy → Hold |
| 2021-12-03 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-10-15 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-10-04 | 재확인 | Jefferies | Buy |
| 2021-09-29 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-09-28 | 다운그레이드 | Berenberg | Buy → Hold |
| 2021-08-13 | 다운그레이드 | Seaport Global Securities | Buy → Neutral |
| 2021-07-07 | 재개 | Keefe Bruyette | Outperform |
| 2021-06-09 | 개시 | Jefferies | Buy |
| 2021-04-21 | 업그레이드 | Berenberg | Hold → Buy |
| 2021-03-02 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2021-01-06 | 개시 | Daiwa Securities | Neutral |
| 2021-01-04 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-11-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-10-13 | 재개 | JP Morgan | Overweight |
| 2020-07-08 | 개시 | Seaport Global Securities | Buy |
| 2020-06-24 | 업그레이드 | DA Davidson | Neutral → Buy |
| 2020-06-23 | 재확인 | UBS | Buy |
| 2020-05-21 | 업그레이드 | Odeon | Hold → Buy |
| 2020-04-14 | 업그레이드 | Societe Generale | Sell → Buy |
| 2020-03-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-02-21 | 다운그레이드 | DA Davidson | Buy → Neutral |
| 2020-02-20 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-01-21 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-01-17 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-01-13 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2020-01-09 | 개시 | DA Davidson | Buy |
| 2020-01-06 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-10-29 | 다운그레이드 | Odeon | Buy → Hold |
| 2019-10-10 | 업그레이드 | Sandler O'Neill | Hold → Buy |
| 2019-07-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-04-18 | 다운그레이드 | Citigroup | Buy → Neutral |
모두보기
모건 스탠리 주식(MS)의 최신 뉴스
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals By Investing.com - Investing.com Canada
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares By Investing.com - Investing.com Canada
Morgan Stanley Adjusts Price Target on Pfizer to $28 From $32, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts PT on Bank of America to $68 From $70, Maintains Overweight Rating - marketscreener.com
Morgan Stanley's long position in H-shares of Jiangsu Hengrui pharmaceuticals decreases to 2.76% on Dec 8HKEX - marketscreener.com
Canada Pension Plan Investment Board Cuts Holdings in Morgan Stanley $MS - MarketBeat
Morgan Stanley upgrades Lottomatica stock to Overweight on favorable outlook - Investing.com
Bayesian Capital Management LP Acquires New Holdings in Morgan Stanley $MS - MarketBeat
Broadcom stock price target raised to $462 by Morgan Stanley on AI growth - Investing.com UK
Morgan Stanley (MS): Revisiting Valuation After Analyst Upgrades and Growing Options Market Interest - Yahoo Finance
Morgan Stanley expects Macau 4Q GGR to grow 8pct sequentially - GGRAsia
Morgan Stanley: Debt financing on the cards for Genting Singapore with SG$5 billion still to spend on RWS 2.0 expansion - IAG – Inside Asian Gaming
Morgan Stanley Lowers Price Target for Evolution to 750 Kronor (830), Maintains Equal WeightBN - marketscreener.com
Morgan Stanley Stock After Hours (Dec. 11, 2025): MS Holds Near a 52-Week High Ahead of Dec. 12 Open — Fed Liquidity, Rate-Cut Path, and Key Levels to Watch - ts2.tech
Adani Power Gets Yet Another Bullish Call From Morgan Stanley — Check Target Price - NDTV Profit
Morgan Stanley Lowers Comcast (CMCSA) Target Amid Shifts in Wireless and Fiber Outlook - Insider Monkey
Verizon (VZ) edges lower in Morgan Stanley’s target reset amid competitive priorities - MSN
Morgan Stanley Adjusts AT&T (T) Targets in Broader Look at the U.S. Wireless Market - Yahoo Finance
Verizon (VZ) Edges Lower in Morgan Stanley’s Target Reset Amid Competitive Priorities - Yahoo Finance
Does Morgan Stanley’s AI Focus Sharpen ASM International’s (ENXTAM:ASM) Strategic Edge in Chip Equipment? - simplywall.st
Fed’s Next Steps and Markets’ Reactions - Morgan Stanley
Morgan Stanley Buys Lower East Side Medical Condo Unit for $56M - Commercial Observer
Form 424B2 MORGAN STANLEY - StreetInsider
Kymera Therapeutics Announces Closing of Upsized $602 Million Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - Benzinga
Rhythm Pharmaceuticals price target raised to $150 from $129 at Morgan Stanley - TipRanks
Form FWP Morgan Stanley Finance Filed by: Morgan Stanley Finance LLC - StreetInsider
Morgan Stanley Just Broke Up with Tesla: Should You Buy or Sell TSLA Stock Here? - Yahoo Finance
Morgan Stanley raises Rhythm Pharmaceuticals stock price target to $150 - Investing.com
Microsoft (MSFT) Announces $23 Billion Investment Plan, Morgan Stanley Reiterates “Buy” Rating - Insider Monkey
Morgan Stanley Has Lowered Expectations for Mondelez International (NASDAQ:MDLZ) Stock Price - MarketBeat
Morgan Stanley Lowers Price Target for MDLZ, Maintains Overweigh - GuruFocus
Morgan Stanley Raises Price Target for Atlantic Union Bankshares (AUB) | AUB Stock News - GuruFocus
ADBE: Morgan Stanley Lowers Price Target to $425 | ADBE Stock Ne - GuruFocus
Morgan Stanley non-response re-alleged abuse at Taiwanese investee - Business and Human Rights Centre
Adobe Outlook Not Yet Inspiring Amid Solid Q4, Morgan Stanley Says - marketscreener.com
REGEuronext DublinGEM-MSBV- Early Redemption-11.12.2025 (MORGAN STANLEY B.V.) [85598] - TradingView
Meta Platforms Could Outperform in 2026 on Revenue, Opex, Model Catalysts, Morgan Stanley Says - marketscreener.com
Morgan Stanley Reaffirms Their Buy Rating on United Rentals (URI) - The Globe and Mail
Morgan Stanley Adjusts PT on Darden Restaurants to $236 From $238, Maintains Overweight Rating - marketscreener.com
Morgan Stanley sees three key catalysts underpinning Meta’s bull case in 2026 - Investing.com
Morgan Stanley Adjusts Price Target on Synopsys to $550 From $510, Maintains Overweight Rating - marketscreener.com
Meta Platforms price target lowered to $750 from $820 at Morgan Stanley - TipRanks
Morgan Stanley $MS Shares Sold by The Manufacturers Life Insurance Company - MarketBeat
Morgan Stanley Adjusts Price Target on Devon Energy to $48 From $47, Maintains Overweight Rating - marketscreener.com
Morgan Stanley sets LA area record for 2025 with $211M purchase - The Real Deal
Oracle (ORCL) Stock Tumbles 13% — And Billionaire David Tepper May Have Seen It Coming. Morgan Stanley Sounds Caution. - TipRanks
Elbit Systems (ESLT) Receives New Coverage from Morgan Stanley | - GuruFocus
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Makes New $7.04 Million Investment in Morgan Stanley $MS - MarketBeat
Morgan Stanley upgrades MP Materials (MP) to overweight on US supply chain push and rare earth outlook - MSN
Morgan Stanley Upgrades MP Materials (MP) to Overweight on US Supply Chain Push and Rare Earth Outlook - Finviz
Morgan Stanley Raises Mirum (MIRM) PT to $95 on Strategic Bluejay Acquisition, Brelovitug Pipeline Addition - Yahoo Finance
모건 스탠리 (MS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.45%
9.05%
자본화:
|
볼륨(24시간):